Author:
Cicinelli Ettore,Cignarelli M.,Petruzzi D.,Matteo M. G.,Ruccia C.,Schonauer L. M.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference15 articles.
1. Cuellar F.G. Bromocriptine mesylate (Parlodel) in the management of amenorrhea-galactorrhea associated with hyperprolactinemia. Obstet. Gynecol. 55: 278, 1980.
2. Friesen H., Tolis G. Use of bromocriptine in the galactorrhea-amenorrhea syndromes. The Canadian Cooperative Study. Clin. Endocrinol. (Oxf.) 6 (suppl): 915, 1977.
3. Metha A.E., Tolis G. Pharmacology of bromocriptine in health and disease. Drugs 77: 313, 1979.
4. Schran H.F., Bhuta S.I., Schwarz H.J., Thorner M.O. The pharmacokinetics of bromocriptine in man. In: Goldstein M., Calne D., Leiberman A., Thorner M.O. (Eds), Ergot compounds and brain function: Neuroendocrine and neuropsychiatric aspects. Raven Press, New York, 1980, p. 125.
5. Montini M., Pagani G., Gianola D., Pagani M.D., Salmoiraghi M., Ferrari L, Lancranjan I. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine. J. Clin. Endocrinol. Metab. 63: 266, 1986.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献